How I Select Patients for Lutetium-PSMA Radioligand Therapy
From #ProsTIC22 Prof Michael Hofman Register now for #ProsTIC24 prostic24.org
▶︎
NCITA Nuclear Medicine in Oncology Workshop – Introduction to Radiopharmacy
▶︎
Treating Lymph Node #ProstateCancer Metastases | #MarkScholzMD #AlexScholz #PCRI
▶︎
Lutetium 177 PSMA - Problems with the Vision Trial
▶︎
02 - New Treatments and Trials: Radioligand Therapy/ PPRT by Dr. Courtney Lawhn Heath
▶︎
mCRPC Lu-177 PSMA and Beyond with Dr. William K. Oh
▶︎
Living With A Pacemaker (common questions answered) - in Plain English!
▶︎
"Understanding Treatments for NETs and Rationale for Sequencing of Therapy" • Dr. Wolin • Apr 1, 25
▶︎
ProsTIC24 - Michael Hofman: How I Select Patients for PSMA Theranostics (PSMA + FDG PET/CT)
▶︎
How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRI
▶︎
Radioligand Therapy for Prostate Cancer
▶︎
The Importance of #ProstateCancer Staging | #MarkScholzMD #AlexScholz #PCRI
▶︎
Multiparametric MRI to Detect Clinically Significant Prostate Cancer: What Urologists Need to Know
▶︎
Chemo, Hormone Therapy, and Radiation For Advanced Metastatic #ProstateCancer #MarkScholzMD #PCRI
▶︎
Seniors No 1 Oncologist Reveals Foods to Starve Cancer Cells Naturally After 50! |Dr. William Li
▶︎
Small Cell Lung Cancer/ Small Cell Carcinoma
▶︎
PET/CT Basics
![PSMAfore Results: [177Lu]Lu-PSMA-617 in Taxane-Naive Patients With mCRPC](https://i.ytimg.com/vi/upLVFTNeq9o/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLBB-inb_XlAgEULYK-NjHNHRSQdzg)
▶︎
PSMAfore Results: [177Lu]Lu-PSMA-617 in Taxane-Naive Patients With mCRPC
▶︎
3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI
▶︎
The Immunotherapy Playbook for Resectable NSCLC
▶︎